Lecanemab and donanemab slow Alzheimer’s decline, but is the benefit worth the cost?
New analysis reveals that lecanemab and donanemab can gradual cognitive decline and prolong sufferers' independence in each day actions. However ...
Tag: Lecanemab
RECOMMENDED
AstraZeneca, Genentech, Roche, Takeda Day 3 news
Adam Feuerstein is a senior author and biotech columnist, reporting on the crossroads of drug growth, enterprise, Wall Avenue, and...
Stay informed with the latest news, articles, and insights on agarwood cultivation, history, sustainability, and more. Explore the timeless allure of agarwood and deepen your understanding of this extraordinary natural resource.